July 7, 2014 — Thoratec Corp. has acquired Apica Cardiovascular Ltd. for an upfront cash payment of $35 million and ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
July 1, 2014 — BioVentrix announced the successful completion of it 50th clinical case using the Revivent myocardial ...
June 23, 2014 — Men who reported being sedentary, with low levels of physical activity, were at a significantly higher ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
Learn how Lumedx can help hospitals reduce heart failure re-admissions and improve patient care with HealthView Heart ...
Interventional thought leaders at the American College of Cardiology (ACC) 2014 meeting shared their predictions about ...
June 10, 2014 — Mast Therapeutics Inc. announced that, in a placebo-controlled, nonclinical model of chronic heart ...
June 2, 2014 — St. Jude Medical announced the completion of its acquisition of the privately held CardioMEMS Inc ...
May 30, 2014 — The U.S. Food and Drug Administration (FDA) granted market clearance to the CardioMEMS Heart Failure ...
May 23, 2014 — Medtronic announced the results from the first prospective randomized clinical trial to show that ...
May 22, 2014 — A study presented at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions ...
May 22, 2014 — Hospira Inc. issued a nationwide recall to the user level for one lot of Dobutamine Injection, USP, 250 ...
May 7, 2014 — HeartWare Intl. Inc. issued a voluntary Urgent Medical Device Correction related to all HeartWare ...
April 30, 2014 — Celladon Corp. announced its lead product candidate, Mydicar, has been granted breakthrough therapy ...
April 28, 2014 — An Arizona State University research group and medical professionals at Phoenix Children’s Hospital are ...
April 25, 2014 — Vanderbilt Heart and Vascular Institute (VHVI) was the first facility in Tennessee to implant the ...